# Oral dIuretics in Very Intensive Treatment, an Early Intervention in Outpatients With Heart Failure

> **NCT03709160** · PHASE4 · UNKNOWN · sponsor: **Centro en Insuficiencia Cardiaca, Mexico** · enrollment: 40 (estimated)

## Conditions studied

- Heart Failure
- Congestive Heart Failure

## Interventions

- **DRUG:** Bumetanide 1 MG

## Key facts

- **NCT ID:** NCT03709160
- **Lead sponsor:** Centro en Insuficiencia Cardiaca, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-15
- **Primary completion:** 2019-10-15
- **Final completion:** 2019-10-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2018-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03709160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03709160, "Oral dIuretics in Very Intensive Treatment, an Early Intervention in Outpatients With Heart Failure". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03709160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*